Interaction Between Cannabidiol, Meal Ingestion, and Liver Function
NCT04971837 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26
Last updated 2024-11-15
Summary
According to a recent consumer poll, over 20 million Americans regularly use cannabidiol (CBD). Moreover, 64 million Americans (over 25% of the population) report trying CBD at least once within the previous 2 years. Since the passing of the 2018 Agriculture Improvement Act, the use of hemp-derived products, such as CBD, is highly prevalent across North America. The acceleration of the use of CBD has outpaced our understanding of the associated potential risks and benefits, and the way it is processed within the body.
In the current proposed project, investigators wish to continue our ongoing collaboration with Caliper Foods, a Colorado-based manufacturer of CBD products. The focus of this project is three-fold: (1) investigators will compare the pharmacokinetics of different formulations of ingestible CBD; (2) investigators will examine the potential two-way interaction between a meal and one formulation of ingestible CBD; and, (3) investigators will examine the influence of different formulations of CBD on markers of liver function.
Conditions
- Metabolism
- Liver Function
- Pharmacokinetics
Interventions
- DIETARY_SUPPLEMENT
-
Cannabidiol (CBD) powder formulation
T-P-S-10 Caliper powder - 30 mg CBD in the form of 300 mg of 10% CBD isolate (Formulation 725: Water soluble.Contains sorbitol)
- DIETARY_SUPPLEMENT
-
Cannabidiol (CBD) Oil based tincture formulation
30 mg CBD isolate in MCT oil,1:1 ratio of CBD to Medium Chain Triglycerides oil. (Formulation 088: Not water soluble. Contains medium chain triglyceride coconut oil.)
- DIETARY_SUPPLEMENT
-
Cannabidiol (CBD) Gum Arabic, maltodextrin base formulation
10% CBD Gum Arabic, maltodextrin base(Formulation 126: Water soluble. Contains gum arabic and maltodextrin)
- DIETARY_SUPPLEMENT
-
Cannabidiol (CBD) Gum Arabic, sorbitol base formulation
10% CBD Gum Arabic, sorbitol base (Formulation 213: Water soluble. Contains gum arabic and sorbitol)
- DIETARY_SUPPLEMENT
-
Cannabidiol (CBD) Isolate in water formulation
Pure CBD as crystalline powder (\>99% purity) (Formulation 625 Not water soluble)
- DIETARY_SUPPLEMENT
-
CBD matching Placebo
Matching Placebo
Sponsors & Collaborators
-
Colorado State University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-05-20
- Primary Completion
- 2021-12-09
- Completion
- 2021-12-09
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Oral THC and CBD in Men and Women
NCT05067387 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adults
NCT05743985 ·Status: COMPLETED ·Phase: NA
-
Cannabidiol and Autonomic Function at Rest
NCT04731779 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Oral Cannabidiol Effect on Blood Pressure in Hypertensive Patients
NCT05346562 ·Status: COMPLETED ·Phase: PHASE1
-
Cannabinoid Supplementation on Vascular and Cognitive Function
NCT03295903 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Pharmacodynamics of Cannabinoid-Caffeine Combinations
NCT05478863 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Cannabis Edibles Packaging Descriptors Experiment
NCT06171399 ·Status: COMPLETED ·Phase: NA
-
A Study of Inhaled Cannabidiol in Healthy Occasional Cannabis Users
NCT05320367 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
RCT-Consumer Perceptions of Cannabidiol (CBD) Health Claims
NCT06800066 ·Status: COMPLETED ·Phase: NA
-
Modulation of THC Effects by CBD: a Dose-ranging Study
NCT06099379 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluation of Smoked THC and CBD in Men and Women
NCT05037487 ·Status: COMPLETED ·Phase: PHASE1
-
Acute Effects of Cannabigerol
NCT05257044 ·Status: COMPLETED ·Phase: PHASE1
-
CBD, Immune Function, and Neural Health
NCT04881539 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Effects of CBD Products on Anxiety Among U.S. Women
NCT05108220 ·Status: COMPLETED
-
Effects of Peppermint Oil in Cardiometabolic Outcomes
NCT05071833 ·Status: COMPLETED ·Phase: NA
-
CHI-907 CBD Extract and Experiences of Test Anxiety
NCT04269252 ·Status: TERMINATED ·Phase: PHASE2
-
Behavioral and Physiological Effects of THC and CBD
NCT03832816 ·Status: WITHDRAWN ·Phase: PHASE1
-
Cannabis and Polysubstance Use: Response Inhibition and Stress Exposure
NCT05261321 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Cannabis Edibles Packaging Imagery Experiment
NCT06358144 ·Status: COMPLETED ·Phase: NA
-
Inulin,SCFA Production and Metabolic Response
NCT02009670 ·Status: COMPLETED ·Phase: NA
-
Effects of Red Beetroot Juice on High-Fat Meal-Induced Endothelial Dysfunction and Cardiometabolic Disturbances
NCT02949115 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessing the Pharmacokinetics and Drug Interaction Liability of Kratom, an Opioid-like Natural Product
NCT04392011 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms
NCT04467918 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Acute Psychological and Physiological Effects of Cannabigerol
NCT06638996 ·Status: RECRUITING ·Phase: NA
-
Effects of Seaweed Extract on Mental Performance Following a High-carbohydrate Meal
NCT03328923 ·Status: COMPLETED ·Phase: NA